ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JISHU DAS MD

Internal Medicine

877

$49.7K

74
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

MALAR RAMASAMY MD

Internal Medicine

860

$40.1K

67
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $61

KARLA MARQUEZ SALAZAR M.D.

Internal Medicine

858

$70.1K

77
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $61

DANIEL COMBS M.D.

Internal Medicine

853

$34.6K

91
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $61

EROMONSELE IDAHOSA MD

Internal Medicine

842

$90.8K

71
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

39%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$108
Average prescription price

Avg: $61

CHRISTOPHER HOFELICH D.O.

Internal Medicine

827

$45.8K

136
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

LISA HARRIS MD

Internal Medicine

823

$46.5K

43
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $61

ANDREW FISCHER M.D.

Internal Medicine

808

$139K

120
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

74%
prescriptions for brand name drugs

Avg: 25%

$172
Average prescription price

Avg: $61

AMI BHIMANI M.D.

Internal Medicine

786

$48.4K

40
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $61

AHMED ABDEL RAHMAN MD

Internal Medicine

772

$30.5K

135
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $61

ADRIAN SINGSON MD

Internal Medicine

770

$51.8K

50
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $61

SARETTE ZAWADSKY

Internal Medicine

767

$40.6K

63
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $61

FIRAS KARA M.D.

Internal Medicine

757

$63.6K

191
28 are 65+

69%
patients receiving schedule two controlled substances

Avg: 6%

32%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$84
Average prescription price

Avg: $61

KATHERINE GILKEY MD

Internal Medicine

751

$36.3K

166
59 are 65+

23%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $61

HAVISHAKRISHNA SARMA DO

Internal Medicine

690

$34.2K

183
78 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

38%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

MADELAINE SGROI DO

Internal Medicine

664

$80.2K

119
98 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $61

GAURAV AGGARWAL MD

Internal Medicine

620

$27.7K

209
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $61

EDWIN SHAKUN M.D.

Internal Medicine

550

$5,668

345
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$10
Average prescription price

Avg: $61

AMY MACKEY MD

Internal Medicine

526

$35.9K

90
32 are 65+

22%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $61

MOHAMMAD TAVASSOLI D.O

Internal Medicine

517

$75.6K

139
56 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

38%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 25%

$146
Average prescription price

Avg: $61

NICHOLAS DELECARIS MD

Internal Medicine

480

$15.3K

56
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$32
Average prescription price

Avg: $61

QAMARUDDOJA KHAN M.D.

Internal Medicine

457

$10.5K

256
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$23
Average prescription price

Avg: $61

JAMES GAITHER M.D.

Internal Medicine

449

$85.1K

63
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

40%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$189
Average prescription price

Avg: $61

BRIAN DARRISAW MD

Internal Medicine

438

$10.4K

255
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$24
Average prescription price

Avg: $61

KEVIN LOGAN M.D.

Internal Medicine

390

$12.1K

37
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$31
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank